Hemgenix (71-75 kg)
Generic name: etranacogene dezaparvovec
Brand names: Hemgenix (101-105 kg), Hemgenix (106-110 kg), Hemgenix (111-115 kg), Hemgenix (116-120 kg), Hemgenix (121-125 kg),
... show all 16 brands
Drug class: Miscellaneous coagulation modifiers
What is Hemgenix (71-75 kg)?
Hemgenix (71-75 kg) is used to treat a bleeding disorder called Hemophilia B in adults who are receiving preventive treatment for the condition, have recurrent episodes of serious bleeding or have current or previous life-threatening bleeding events.
Hemgenix (71-75 kg) may also be used for purposes not listed in this medication guide.
Hemgenix (71-75 kg) side effects
Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.
Some side effects may occur during or right after the injection. Tell your medical caregiver if you feel dizzy, nauseated, light-headed, itchy, sweaty, or have a headache, chest tightness, back pain, trouble breathing, unusual bleeding, or swelling in your face.
Common side effects of Hemgenix (71-75 kg) may include:
-
abnormal blood tests;
-
headache;
-
flu-like symptoms;
-
a reaction after receiving injection; or
-
feeling weak or tired, body aches.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Warnings
Tell your doctor if you use other medicines or have other medical conditions or allergies.
Before taking this medicine
Tell your doctor if you have or have ever had:
-
unusual bleeding, any bleeding that will not stop;
-
hepatitis B or C;
-
if you drink large amounts of alcohol; or
-
cirrhosis or other liver disease.
Hemgenix (71-75 kg) is not intended for use by women.
How is Hemgenix (71-75 kg) given?
Your doctor will perform medical tests before starting treatment with Hemgenix (71-75 kg) to make sure is the right treatment for you.
Hemgenix (71-75 kg) is injected into a vein by a healthcare provider.
You will be watched during and for at least 3 hours after the infusion to make sure you do not have a reaction.
Doses are based on weight. Your dose may change if you gain or lose weight.
You will need weekly blood tests to check your liver function for 3 months after treatment.
You may be prescribed other medications to help treat abnormal liver function tests. Keep taking these medicines for as long as your doctor has prescribed.
You may need other medical tests for a longer period of time if you have certain conditions or if you have certain side effects.
Related/similar drugs
Idelvion, Beqvez, Hympavzi, BeneFix, NovoSeven RT, Alprolix, coagulation factor ix
What happens if I miss a dose?
Call your doctor for instructions if you miss an appointment for your Hemgenix (71-75 kg).
What happens if I overdose?
In a medical setting an overdose would be treated quickly.
What should I avoid after receiving Hemgenix (71-75 kg)?
Do not donate blood, organs, tissues, or cells for transplantation after receiving Hemgenix (71-75 kg).
What other drugs will affect Hemgenix (71-75 kg)?
Other drugs may affect Hemgenix (71-75 kg), including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.
Popular FAQ
Why is Hemgenix the most expensive drug in the world?
More about Hemgenix (etranacogene dezaparvovec)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous coagulation modifiers
Patient resources
- Hemgenix drug information
- Hemgenix (101-105 kg)
- Hemgenix (106-110 kg)
- Hemgenix (111-115 kg)
- Hemgenix (116-120 kg)
Professional resources
Related treatment guides
Further information
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2024 Cerner Multum, Inc. Version: 1.01.